Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.4 DKK | -2.22% | -6.71% | -3.83% |
Apr. 23 | Transcript : Embla Medical hf., Q1 2024 Earnings Call, Apr 23, 2024 | |
Apr. 23 | Embla Medical hf. Provides Earnings Guidance for the Year 2024 | CI |
Sales 2024 * | 869M 6B | Sales 2025 * | 945M 6.52B | Capitalization | 1.63B 11.27B |
---|---|---|---|---|---|
Net income 2024 * | 72M 497M | Net income 2025 * | 86M 594M | EV / Sales 2024 * | 2.35 x |
Net Debt 2024 * | 412M 2.84B | Net Debt 2025 * | 383M 2.64B | EV / Sales 2025 * | 2.13 x |
P/E ratio 2024 * |
21.6
x | P/E ratio 2025 * |
18.1
x | Employees | 4,000 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 48.4% |
Latest transcript on Embla Medical hf.
1 day | -2.22% | ||
1 week | -6.71% | ||
Current month | -6.71% | ||
1 month | -10.51% | ||
3 months | -15.92% | ||
6 months | -4.35% | ||
Current year | -3.83% |
Managers | Title | Age | Since |
---|---|---|---|
Sveinn Sölvason
CEO | Chief Executive Officer | 46 | 08-12-31 |
Director of Finance/CFO | 58 | 22-08-31 | |
Lukas Märklin
COO | Chief Operating Officer | - | 23-06-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 73 | 13-02-28 | |
Niels Jacobsen
CHM | Chairman | 66 | 04-12-31 |
Svafa Grönfeldt
BRD | Director/Board Member | 59 | 08-01-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 26.4 | -2.22% | 34,890 |
24-06-06 | 27 | -3.23% | 28,620 |
24-06-04 | 27.9 | 0.00% | 21,548 |
24-06-03 | 27.9 | -1.41% | 40,321 |
24-05-31 | 28.3 | +0.71% | 8,635 |
Delayed Quote Nasdaq Copenhagen, June 07, 2024 at 10:59 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.83% | 1.68B | |
-13.90% | 21.09B | |
+5.10% | 19.33B | |
+12.84% | 10.55B | |
-20.92% | 2.01B | |
+9.55% | 1.36B | |
+3.95% | 554M | |
0.00% | 403M | |
+57.45% | 186M | |
+20.04% | 93.9M |
- Stock Market
- Equities
- EMBLA Stock